OBIO – orchestra biomed holdings, inc. - ordinary shares (US:NASDAQ)
Stock Stats
News
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) had its price target lowered by analysts at HC Wainwright from $14.00 to $12.00. They now have a "buy" rating on the stock.
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) is now covered by analysts at BTIG Research. They set a "buy" rating and a $12.00 price target on the stock.
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Form 4 Orchestra BioMed Holding For: Apr 04 Filed by: Hochman David P
Form 4 Orchestra BioMed Holding For: Apr 04 Filed by: Aiello Joshua
Form 4 Orchestra BioMed Holding For: Apr 04 Filed by: Sherman Darren
Form 4 Orchestra BioMed Holding For: Apr 04 Filed by: Taylor Andrew Lawrence
Form 10-K Orchestra BioMed Holding For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.